Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Androgel

Testosterone

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Androgel:

 BioPortfolio Logo
Androgel Manufacturers Sued in Class Action for Antitrust Violations 7th April, 2009 RodaNast, P.C.
LANCASTER, Pa., April 7 /PRNewswire-USNewswire/ -- A class action complaint filed last week in New Jersey federal court claims damages for violations of the Sherman Antitrust Act by brand-name and
Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results 2nd March, 2009 Par Pharmaceutical Companies, Inc.
Reports Adjusted Q4 EPS of $0.21 WOODCLIFF LAKE, N.J., March 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported fourth quarter and full year 2008 results ended

This page has been viewed 16 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Androgel across BioPortfolio, or for Androgel Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.